FDA Label for Novavax Covid-19 Vaccine, Adjuvanted
View Indications, Usage & Precautions
Novavax Covid-19 Vaccine, Adjuvanted Product Label
The following document was submitted to the FDA by the labeler of this product Novavax, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package/Label Display Panel – Vial Label
NDC 80631-100-01
NOVAVAX
COVID-19 Vaccine,
Adjuvanted
Suspension for intramuscular injection
Multi-dose vial (10 doses of 0.5 mL)
Record date/time of first use:
Date: Time:
Manufactured for:
Novavax, Inc., Gaithersburg, MD 20878
Package/Label Display Panel – Vial Carton
NDC 80631-100-10
10 Multi-Dose Vials
(each vial contains 10 doses of 0.5 mL)
NOVAVAX
COVID-19 Vaccine, Adjuvanted
suspension for
intramuscular injection
For use under Emergency Use Authorization
NOVAVAX
* Please review the disclaimer below.